 | • レポートコード：MRC2012B0318 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、急性虚血性脳卒中の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性虚血性脳卒中の種類別市場規模（降圧薬、抗血小板薬、抗凝固薬）、用途別市場規模（病院、外来手術センター、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Sanofi、Boehringer Ingelheim、Pfizer、Roche、Daiichi Sankyo、Biogen、 ・地域別グローバル市場分析 2015年-2020年 ・急性虚血性脳卒中の北米市場（アメリカ、カナダ、メキシコ） ・急性虚血性脳卒中のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・急性虚血性脳卒中のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・急性虚血性脳卒中の南米市場（ブラジル、アルゼンチン） ・急性虚血性脳卒中の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：降圧薬、抗血小板薬、抗凝固薬 ・用途別分析：病院、外来手術センター、診断センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Acute Ischemic Stroke market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Acute Ischemic Stroke market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Acute Ischemic Stroke market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acute Ischemic Stroke market has been segmented into:
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants
By Application, Acute Ischemic Stroke has been segmented into:
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Ischemic Stroke market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Ischemic Stroke markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Ischemic Stroke market.
The report offers in-depth assessment of the growth and other aspects of the Acute Ischemic Stroke market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Acute Ischemic Stroke Market Share Analysis
Acute Ischemic Stroke competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Ischemic Stroke sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Ischemic Stroke sales, revenue and market share for each player covered in this report.
The major players covered in Acute Ischemic Stroke are:
Bayer
Sanofi
Boehringer Ingelheim
Pfizer
Roche
Daiichi Sankyo
Biogen
Among other players domestic and global, Acute Ischemic Stroke market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Acute Ischemic Stroke Market Overview
1.1 Product Overview and Scope of Acute Ischemic Stroke
1.2 Classification of Acute Ischemic Stroke by Type
1.2.1 Global Acute Ischemic Stroke Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Ischemic Stroke Revenue Market Share by Type in 2019
1.2.3 Antihypertensive Therapeutics
1.2.4 Antiplatelet Therapeutics
1.2.5 Anticoagulants
1.3 Global Acute Ischemic Stroke Market by Application
1.3.1 Overview: Global Acute Ischemic Stroke Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Global Acute Ischemic Stroke Market by Regions
1.4.1 Global Acute Ischemic Stroke Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Ischemic Stroke (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Ischemic Stroke Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Ischemic Stroke Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Ischemic Stroke Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Ischemic Stroke Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Ischemic Stroke Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim SWOT Analysis
2.3.4 Boehringer Ingelheim Product and Services
2.3.5 Boehringer Ingelheim Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
2.6 Daiichi Sankyo
2.6.1 Daiichi Sankyo Details
2.6.2 Daiichi Sankyo Major Business
2.6.3 Daiichi Sankyo Product and Services
2.6.4 Daiichi Sankyo Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biogen
2.7.1 Biogen Details
2.7.2 Biogen Major Business
2.7.3 Biogen Product and Services
2.7.4 Biogen Acute Ischemic Stroke Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Ischemic Stroke Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Ischemic Stroke Players Market Share
3.2.2 Top 10 Acute Ischemic Stroke Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Ischemic Stroke Revenue and Market Share by Regions
4.2 North America Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
4.5 South America Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
5 North America Acute Ischemic Stroke Revenue by Countries
5.1 North America Acute Ischemic Stroke Revenue by Countries (2015-2020)
5.2 USA Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
6 Europe Acute Ischemic Stroke Revenue by Countries
6.1 Europe Acute Ischemic Stroke Revenue by Countries (2015-2020)
6.2 Germany Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
6.3 UK Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
6.4 France Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Ischemic Stroke Revenue by Countries
7.1 Asia-Pacific Acute Ischemic Stroke Revenue by Countries (2015-2020)
7.2 China Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
7.5 India Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
8 South America Acute Ischemic Stroke Revenue by Countries
8.1 South America Acute Ischemic Stroke Revenue by Countries (2015-2020)
8.2 Brazil Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Ischemic Stroke by Countries
9.1 Middle East & Africa Acute Ischemic Stroke Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Ischemic Stroke Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Ischemic Stroke Market Forecast by Type (2019-2024)
10.3 Antihypertensive Therapeutics Revenue Growth Rate (2015-2025)
10.4 Antiplatelet Therapeutics Revenue Growth Rate (2015-2025)
10.5 Anticoagulants Revenue Growth Rate (2015-2025)
11 Global Acute Ischemic Stroke Market Segment by Application
11.1 Global Acute Ischemic Stroke Revenue Market Share by Application (2015-2020)
11.2 Acute Ischemic Stroke Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Center Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Acute Ischemic Stroke Market Size Forecast (2021-2025)
12.1 Global Acute Ischemic Stroke Market Size Forecast (2021-2025)
12.2 Global Acute Ischemic Stroke Market Forecast by Regions (2021-2025)
12.3 North America Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
12.4 Europe Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
12.6 South America Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Acute Ischemic Stroke Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Ischemic Stroke by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Ischemic Stroke Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acute Ischemic Stroke Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Acute Ischemic Stroke Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bayer Corporate Information, Location and Competitors
Table 7. Bayer Acute Ischemic Stroke Major Business
Table 8. Bayer Acute Ischemic Stroke Total Revenue (USD Million) (2017-2018)
Table 9. Bayer SWOT Analysis
Table 10. Bayer Acute Ischemic Stroke Product and Solutions
Table 11. Bayer Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Sanofi Corporate Information, Location and Competitors
Table 13. Sanofi Acute Ischemic Stroke Major Business
Table 14. Sanofi Acute Ischemic Stroke Total Revenue (USD Million) (2018-2019)
Table 15. Sanofi SWOT Analysis
Table 16. Sanofi Acute Ischemic Stroke Product and Solutions
Table 17. Sanofi Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 19. Boehringer Ingelheim Acute Ischemic Stroke Major Business
Table 20. Boehringer Ingelheim Acute Ischemic Stroke Total Revenue (USD Million) (2017-2018)
Table 21. Boehringer Ingelheim SWOT Analysis
Table 22. Boehringer Ingelheim Acute Ischemic Stroke Product and Solutions
Table 23. Boehringer Ingelheim Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Pfizer Corporate Information, Location and Competitors
Table 25. Pfizer Acute Ischemic Stroke Major Business
Table 26. Pfizer Acute Ischemic Stroke Total Revenue (USD Million) (2017-2018)
Table 27. Pfizer SWOT Analysis
Table 28. Pfizer Acute Ischemic Stroke Product and Solutions
Table 29. Pfizer Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Roche Corporate Information, Location and Competitors
Table 31. Roche Acute Ischemic Stroke Major Business
Table 32. Roche Acute Ischemic Stroke Total Revenue (USD Million) (2017-2018)
Table 33. Roche SWOT Analysis
Table 34. Roche Acute Ischemic Stroke Product and Solutions
Table 35. Roche Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Daiichi Sankyo Corporate Information, Location and Competitors
Table 37. Daiichi Sankyo Acute Ischemic Stroke Major Business
Table 38. Daiichi Sankyo Acute Ischemic Stroke Total Revenue (USD Million) (2017-2018)
Table 39. Daiichi Sankyo SWOT Analysis
Table 40. Daiichi Sankyo Acute Ischemic Stroke Product and Solutions
Table 41. Daiichi Sankyo Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Biogen Corporate Information, Location and Competitors
Table 43. Biogen Acute Ischemic Stroke Major Business
Table 44. Biogen Acute Ischemic Stroke Total Revenue (USD Million) (2017-2018)
Table 45. Biogen SWOT Analysis
Table 46. Biogen Acute Ischemic Stroke Product and Solutions
Table 47. Biogen Acute Ischemic Stroke Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Acute Ischemic Stroke Revenue (Million USD) by Players (2015-2020)
Table 49. Global Acute Ischemic Stroke Revenue Share by Players (2015-2020)
Table 50. Global Acute Ischemic Stroke Revenue (Million USD) by Regions (2015-2020)
Table 51. Global Acute Ischemic Stroke Revenue Market Share by Regions (2015-2020)
Table 52. North America Acute Ischemic Stroke Revenue by Countries (2015-2020)
Table 53. North America Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Table 54. Europe Acute Ischemic Stroke Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific Acute Ischemic Stroke Revenue (Million USD) by Countries (2015-2020)
Table 56. South America Acute Ischemic Stroke Revenue by Countries (2015-2020)
Table 57. South America Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa Acute Ischemic Stroke Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Table 60. Global Acute Ischemic Stroke Revenue (Million USD) by Type (2015-2020)
Table 61. Global Acute Ischemic Stroke Revenue Share by Type (2015-2020)
Table 62. Global Acute Ischemic Stroke Revenue Forecast by Type (2021-2025)
Table 63. Global Acute Ischemic Stroke Revenue by Application (2015-2020)
Table 64. Global Acute Ischemic Stroke Revenue Share by Application (2015-2020)
Table 65. Global Acute Ischemic Stroke Revenue Forecast by Application (2021-2025)
Table 66. Global Acute Ischemic Stroke Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acute Ischemic Stroke Picture
Figure 2. Global Acute Ischemic Stroke Revenue Market Share by Type in 2019
Figure 3. Antihypertensive Therapeutics Picture
Figure 4. Antiplatelet Therapeutics Picture
Figure 5. Anticoagulants Picture
Figure 6. Acute Ischemic Stroke Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Ambulatory Surgical Center Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Global Acute Ischemic Stroke Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Acute Ischemic Stroke Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Acute Ischemic Stroke Revenue Market Share in 2019
Figure 19. Global Top 10 Players Acute Ischemic Stroke Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Acute Ischemic Stroke Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Acute Ischemic Stroke Revenue Market Share by Regions (2015-2020)
Figure 23. Global Acute Ischemic Stroke Revenue Market Share by Regions in 2018
Figure 24. North America Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 25. Europe Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 27. South America Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 29. North America Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Figure 30. North America Acute Ischemic Stroke Revenue Market Share by Countries in 2019
Figure 31. USA Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 32. Canada Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 34. Europe Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Acute Ischemic Stroke Revenue Market Share by Countries in 2019
Figure 36. Germany Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 37. UK Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 38. France Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 39. Russia Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 40. Italy Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Acute Ischemic Stroke Revenue Market Share by Countries in 2019
Figure 43. China Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 44. Japan Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 45. Korea Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 46. India Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 48. South America Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Figure 49. South America Acute Ischemic Stroke Revenue Market Share by Countries in 2019
Figure 50. Brazil Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Acute Ischemic Stroke Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Acute Ischemic Stroke Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 55. UAE Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Acute Ischemic Stroke Revenue and Growth Rate (2015-2020)
Figure 58. Global Acute Ischemic Stroke Revenue Share by Type (2015-2020)
Figure 59. Global Acute Ischemic Stroke Revenue Share by Type in 2019
Figure 60. Global Acute Ischemic Stroke Market Share Forecast by Type (2021-2025)
Figure 61. Global Antihypertensive Therapeutics Revenue Growth Rate (2015-2020)
Figure 62. Global Antiplatelet Therapeutics Revenue Growth Rate (2015-2020)
Figure 63. Global Anticoagulants Revenue Growth Rate (2015-2020)
Figure 64. Global Acute Ischemic Stroke Revenue Share by Application (2015-2020)
Figure 65. Global Acute Ischemic Stroke Revenue Share by Application in 2019
Figure 66. Global Acute Ischemic Stroke Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgical Center Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Acute Ischemic Stroke Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Acute Ischemic Stroke Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Acute Ischemic Stroke Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
Figure 74. Europe Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
Figure 76. South America Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Acute Ischemic Stroke Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
急性虚血性脳卒中治療薬の世界市場（～2026年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…- 虚血性脳卒中予防治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ischemic Cerebral Stroke Prevention Therapeutics Market The global Ischemic Cerebral Stroke Prevention Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ischemic Cerebral…
- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 脳卒中診断・治療の世界市場（～2026年） Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced. Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed …
- 脳卒中管理の世界市場（～2026年） Stroke is the condition that occurs when the clot is formed in the artery and the oxygen supply to the brain is cut off, brain cells get deprived of oxygen and starts to die. Stroke can be thrombotic or embolic. Thrombotic stroke occurs when a blood clot is formed in the arteries that supply blood t…